Foresite Capital Fund IV, L.P. 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 4:01 pm Unchanged | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Foresite Capital Fund IV, L.P. | 2,457,108 5.600% | 0 (Unchanged) | Filing |
| 2025-02-07 4:01 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Foresite Capital Fund IV, L.P. | 2,457,108 5.600% | 2,457,108 (New Position) | Filing |